
[Federal Register Volume 77, Number 154 (Thursday, August 9, 2012)]
[Notices]
[Pages 47652-47653]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-19549]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0001]


Second Annual Food and Drug Administration Health Professional 
Organizations Conference

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of conference.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a conference 
for representatives of health professional organizations. Topics on the 
agenda include an update on the FDA Safety and Innovation Act (Pub. L. 
112-144) and an overview of FDA's Network of Experts (public/private 
partnerships).
    The afternoon will consist of interactive breakout sessions 
facilitated by FDA staff from various Centers and Offices, including a 
networking session to meet FDA personnel.

DATES:  Date and Time: The conference will be held on October 4, 2012, 
from 9 a.m. to 4 p.m.
    Location: The conference will be held at FDA White Oak Campus, 
10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room 
(rm. 1503), Silver Spring, MD 20993.
    Contact Person: Janelle Derbis, Office of Special Health Issues, 
Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, 
MD 20993, 301-796-8460, email: Janelle.Derbis@fda.hhs.gov.
    Registration: Register at: https://www.surveymonkey.com/s/FDAConference. Please include the name and title of the person 
attending, the name of the organization, and email address. There is no 
registration fee for this conference. Early registration is suggested 
because space is limited.

SUPPLEMENTARY INFORMATION: The aim of the conference is to further the 
public health mission of FDA through training,

[[Page 47653]]

collaboration, and structured discussion between health professional 
organizations and FDA staff. The Office of Special Health Issues serves 
as a liaison between FDA Centers and the public on matters that involve 
medical product safety and also acts as the public's link to 
information about the medical product approval process.
    The conference will include breakout session topics from various 
FDA Centers including a discussion on the usability and content of 
FDA's Web site, information on what happens after you submit a MedWatch 
report, protecting patients from counterfeit and other substandard 
drugs/supply chain threats, and others. The goal of the breakout 
sessions is to exchange ideas and to encourage collaboration to promote 
public health. Please indicate during your registration the topics of 
greatest interest to you for the breakout sessions.
    If you need special accommodations due to a disability, please 
inform Janelle Derbis, Janelle.Derbis@fda.hhs.gov, at least 7 days in 
advance of the conference.

    Dated: August 3, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-19549 Filed 8-8-12; 8:45 am]
BILLING CODE 4160-01-P


